1-2 of 2
Graciela Avila, MD
Close
Sort by
Journal Articles

90 Y-Ibritumomab Treatment for Relapsed and/or Refractory B Cell Type Non-Hodgkin’s Lymphoma. Multiinstitutional Argentinian Study.

Roberto Cacchione, MD, Juan Dupont, MD, Jorge Milone, MD, Javier Bordone, MD, Guy Garay, MD, Maria Ardaiz, MD, Miguel Castro-Rios, MD, Virginia Prates, MD, Alfredo Basso, MD, Marcelo Iabstrebner, MD, Graciela Avila, MD, Alicia Diaz, MD, Daniel Argentieri, MD, Silvia Rudoy, MD, Alicia Trouboul, MD, Luis Palmer, MD, Gonzalo Pombo, MD, Silvina Rappaciotti, MD, Pedro Negri, MD, Diana Lafalse, MD, Leandro Riera, MD, Miguel de Tezanos-Pinto, MD, Dardo Riveros, MD, Mario Brown Arnold, MD, Antonio Carrasco, MD, Fernando Bezares, MD
Journal: Blood
Blood (2007) 110 (11): 4484.
https://doi.org/10.1182/blood.V110.11.4484.4484
Published: 2007
Journal Articles

Risk-Oriented Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT). Final Results of the Argentinian Group for Treatment of Acute Leukemia (GATLA) Phase III Study.

Santiago Pavlovsky, MD, PhD, Claudia S. Corrado, MD, Miguel A. Pavlovsky, MD, Virginia Prates, MD, Lucia Zoppegno, MD, Mario Giunta, MD, Ider Cerutti, MD, Elsa Palomino, MD, Fernando Pagani, MD, Francisco Lastiri, MD, Maria C. Narbaitz, MD, Fernando Cavagnaro, MD, Graciela Avila, MD
Journal: Blood
Blood (2006) 108 (11): 2474.
https://doi.org/10.1182/blood.V108.11.2474.2474
Published: 2006